Nippon Life Insurance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-81,215
Closed -$5.18M – 67
2017
Q3
$5.18M Buy
81,215
+103
+0.1% +$6.01K 0.1% 57
2017
Q2
$4.52M Sell
81,112
-1,655
-2% -$90.1K 0.09% 60
2017
Q1
$4.5M Buy
82,767
+11,644
+16% +$639K 0.09% 61
2016
Q4
$4.16M Sell
71,123
-3,901
-5% -$213K 0.08% 67
2016
Q3
$4.04M Sell
75,024
-36
-0% -$2.31K 0.09% 67
2016
Q2
$5.52M Sell
75,060
-1,041
-1% -$73.6K 0.14% 46
2016
Q1
$4.86M Buy
76,101
+301
+0.4% +$19K 0.12% 55
2015
Q4
$5.21M Sell
75,800
-3,796
-5% -$251K 0.13% 51
2015
Q3
$4.71M Sell
79,596
-15
-0% -$952 0.12% 57
2015
Q2
$5.3M Sell
79,611
-6,078
-7% -$401K 0.13% 53
2015
Q1
$5.53M Sell
85,689
-2,907
-3% -$182K 0.14% 55
2014
Q4
$5.23M Buy
88,596
+2,076
+2% +$117K 0.13% 56
2014
Q3
$4.43M Buy
86,520
+7,079
+9% +$354K 0.11% 70
2014
Q2
$3.85M Sell
79,441
-17,313
-18% -$853K 0.1% 78
2014
Q1
$5.03M Buy
96,754
+3,657
+4% +$195K 0.14% 57
2013
Q4
$4.95M Buy
93,097
+4,932
+6% +$251K 0.14% 60
2013
Q3
$4.08M Sell
88,165
-6,692
-7% -$294K 0.13% 68
2013
Q2
$4.24M Buy
+94,857
New +$4.12M 0.14% 66

Other funds holding BMY

Nippon Life Insurance's BMY Position: Q4 2017 in Review

Nippon Life Insurance sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 81,215 shares — an estimated $5.18M sold.

Nippon Life Insurance first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $5.53M in Q1 2015. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Nippon Life Insurance reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 81,215 Bristol-Myers Squibb shares in Q4 2017, an estimated $5.18M.
  • Nippon Life Insurance first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
  • Nippon Life Insurance's Bristol-Myers Squibb position peaked at $5.53M in Q1 2015.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.